Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNaftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Cochrane Reviews, 10/20/09
Garimella PS et al. – This review of eight trials evaluated naftopidil for the treatment of BPH. Current evidence is sparse. The authors did not identify any placebo–controlled trials. Naftopidil had a similar short–term efficacy and adverse–effect profile compared to low–dose tamsulosin, and better efficacy than phytotherapy (eviprostat). Adverse effects of naftopidil were few, most commonly dizziness and hypotension. Prior to wide–spread use, more long–term, randomized, controlled studies compared to standard therapy are needed.
Related Articles
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia
The Prostate, 11/18/09
Relevance Score: 68%
Resistive Index: A Newly Identified Predictor of Outcome of Transurethral Prostatectomy in Patients With Benign Prostatic Hyperplasia
Urology, 11/12/09
Relevance Score: 68%
Differences in Initial Benign Prostatic Hyperplasia Management Between Primary Care Physicians and Urologists
The Journal of Urology, 11/02/09
Relevance Score: 67%
Stone Formation in Prostatic Urethra After Potassium-Titanyl-Phosphate Laser Ablation of the Prostate for Benign Prostatic Hyperplasia
Journal of Endourology, 10/13/09
Relevance Score: 67%
Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world
Indian Journal of Urology, 10/08/09
Relevance Score: 66%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol
Therapeutics and Clinical Risk Management, 12/09/09
Pharmacotherapy of diabetic foot osteomyelitis
Expert Opinion in Pharmacotherapy, 12/09/09
Sponsor
Article Search
Sponsor